Imirestat (AL 1576) is an aldose reductase inhibitor, used for the treatment of diabetes.
In Vivo
Imirestat (1 mg/kg) improves nerve conduction velocity but is without effect upon the resistance to hypoxic conduction blockade or the deficit in insulin-stimulated oubain-sensitive ATPase activity . MCE has not independently confirmed the accuracy of these methods. They are for reference only.
